medigraphic.com
ISSN 1870-199X (Print)
Órgano oficial de la Facultad de Odontología, UNAM

2007, Number 1

<< Back Next >>

Rev Odont Mex 2007; 11 (1)

Prisoners alterations of the oral mucosa in Mexico

Esquivel-Pedraza L, Fernández-Cuevas L, Ruíz-Badillo A, Magis-Rodríguez C

Language: Spanish
References: 38
Page: 38-45
PDF size: 177.41 Kb.


ABSTRACT

Objectives: To establish the prevalence of oral mucosa lesions in a captive population, and to find out the association between oral lesions and history of psychoactive drug use. Methods: Cross-sectional study, performed from October 1999 through December 2004, based on examination of the mouth of prison inmates. The diagnosis of mouth lesions was made according to pre-established clinical criteria. Data related to epidemiological and clinical aspects such as mouth hygiene, use of prosthesis, cutting edges, history of alterations in the oral mucosa, use of tobacco, alcohol and drugs, systemic illnesses, serologic HIV status, sexual practices, and history of psychoactive drug use, were all assessed. Odds ratio and 95% confidence intervals were calculated, χ2 and Fisher’s exact test were used, also a multivariate analysis was performed. Results: Fifty-four subjects (91% male) were studied; median age, 27 years old (range 16-60). A total of 39/52 (75%) had history of psychoactive drug use. Mouth lesions were found in 94% of subjects; the most common being melanotic hyperpigmentation and scars. A higher frequency of melanosis was encountered in marihuana users (p = 0.03); also scars (p = 0.01) were more frequent among anxiolytic users (p = 0.04) than in those using other drugs. In contrast, the lowest prevalence of Fordyce’s disease was encountered among users of heroin alone (p = 0.04), regardless of confounding factors. Conclusions: In our study, prison subjects showed a high frequency of oral mucosa lesions. A close association was found between certain mouth conditions and history of use of some psychoactive drugs.


REFERENCES

  1. Guilliard D, Beck A. Bureau of Justice Statistics: prison and jail inmates at midyear, 1997. Washington DC: US Department of Justice, 1998.

  2. Country reports on human rights practices-2003. Released by the Bureau of Democracy, Human Rights, and Labor. U.S. Department of State. Available: http://www.state.gov/g/drl/ rls/hrrpt/2003/27905.htm (accessed 2004 Feb 25).

  3. Hutchinson C. Health care for prisoners: humane—and the law. Infections Med 1998; 15: 160-1.

  4. Teplin LA, Abram KM, McClelland GM. Prevalence of psychiatric disorders among incarcerated women. I. Pretrial jail detainees. Arch Gen Psychiatry 1996; 53: 505-12.

  5. Cravioto P, Medina-Mora ME, De-la-Rosa B, Galván F, Tapia-Conyer R. Patrones de consumo de heroína en una cárcel de la frontera norte de México: barreras de acceso a tratamiento. Salud Pública Mex 2003; 45: 181-90.

  6. Chitwood DD, Sánchez J, Comerford M, McCoy CB. Primary preventive health care among injection drug users, other sustained drug users, and non –users. Subst Use Misuse 2001; 36: 807-824.

  7. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689-95.

  8. Medical consequences of drug abuse. NIDA Drugs of abuse and related topics. National Institute on Drug Abuse. The science of drug abuse & addiction. Available: http://www.drugabuse.gov/consequences/index.html (accessed 2002 Jul 3).

  9. Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003; 16(2): 209-19.

  10. Kennedy NJ. Efectos clínicos de las drogas psicoactivas: ¿dañinas o terapéuticas? En: Tapia-Conyer R, ed. Las adicciones: dimensión, impacto y perspectivas. México, D.F.: El Manual Moderno; 1994: 285-305.

  11. Fazzi M, Vescovi P, Savi A, Manfredi M, Peracchia M. Effetti delle droghe sul cavo orale. Minerva Stomatol 1999; 48: 485-92.

  12. Rosenstein DI, Stewart AV. Dental care for patients receiving methadone. JADA 1974; 89: 356-9.

  13. Ruíz-Badillo A, Magis-Rodríguez C, Ortíz-Mondragón R, Lozada-Romero R. Conocimientos, percepción y prácticas de riesgo para adquirir el VIH en inyectores de drogas de Tijuana, B.C. Psi Soc Mex 1998; 7: 266-71.

  14. World Health Organization. Guide to epidemiology and diagnosis of oral mucosal diseases and conditions. Community Dent Oral Epidemiol 1980; 8: 1-26.

  15. EC-Clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on oral manifestations of the immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289-91.

  16. Greene JC, Vermillion JR. The simplified oral hygiene index. JADA 1964; 68: 7-13.

  17. Hurlen B, Jacobsen N, Hurlen P. Hepatitis B serum markers and oral health in a group of Norwegian male prisoners. Acta Odontol Scand 1984; 42: 53-8.

  18. Esparza-Gómez GC, García Pola VMJ, Aguirre-Urizar JM, Girón MFJ. Prevalence of oral lesions diagnosed in a group of intravenous drug addict prisoners with AIDS and their correlation with CD4 lymphocyte count. Med Clin (Barc) 1998: 110-9.

  19. Lamster IB, Begg MD, Mitchell-Lewis D, Fine JB, Grbic JT, Todak CG, el-Sadr W, Gorman JM, Zambon JJ, Phelan JA. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical and immunologic parameters to oral lesions. Oral Surg, Oral Med, Oral Pathol 1994; 78: 163-74.

  20. Barone R, Ficarra G, Gaglioti D, Orsi A, Mazzotta F. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg, Oral Med, Oral Pathol 1990; 69: 169-73.

  21. Schmidt-Westhausen A, Grünewald T, Reichart PA, Pohle HD. Oral manifestations in 70 German HIV-infected women. Oral Dis 1997; 3(Suppl 1): S28-S30.

  22. Di Cugno F. Efecto del consumo de drogas sobre tejidos y órganos bucales. Bol Oficina Sanit Panam 1979; 87: 300-8.

  23. Darling MR, Arendorf TM. Effects of cannabis smoking on oral soft tissues. Community Dent Oral Epidemiol 1993; 21: 78-81.

  24. Donta AN, Lampadakis J, Pilalitos P, Spyropoulos ND. Findings from the clinical examination of the oral cavity of one hundred drug addicts. Hell Stomatol Chron 1989; 33: 101-5.

  25. Cho CM, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J 2005; 50: 70-4.

  26. Blanksma CJ, Brand HS. Cocaine abuse: orofacial manifestations and implications for dental treatment. Int Dent J 2005; 55: 365-9.

  27. Heymann WR. Psychotropic agent-induced black hairy tongue. Cutis 2000; 66: 25-6.

  28. Mitchell-Lewis DA, Phelan J, Kelly RB, Bradley JJ, Lamster IB. Identifying oral lesions associated with crack cocaine use. JADA 1994; 125: 1104-8, 1110.

  29. Darling MR, Arendorf TM. Review of the effects of cannabis smoking on oral health. Int Dent J 1992; 42: 19-22.

  30. Gahlinger PM. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), rohypnol, and ketamine. Am Fam Physician 2004; 69: 2619-2626.

  31. Heidin CA, Axéll T. Oral melanin pigmentation in 467 Thai and Malaysian people with special emphasis on smoker’s melanosis. J Oral Pathol Med 1991; 20: 8-12.

  32. Ramírez V, Mosqueda A, Hernández H. Estudio epidemiológico de las lesiones de la mucosa oral. Cuadernos CBS 11, México:UAM-Xochimilco; 1986.

  33. Westerhof W, Wolters EC, Brookbakker JT, Boelen RE, Schipper ME. Pigmented lesions of the tongue in heroin addicts-fixed drug eruption. Br J Dermatol 1983; 109: 605-10.

  34. Gerlach D, Wolters HD. Zahn-und Mundschleimhautbefunde bei Rauschmittelkonsumenten. Dtsch Zahnärztl Z 1977; 32: 400-4.

  35. Tennant F, Shannon JA, Nork JG, Sagherian A, Berman M. Abnormal adrenal gland metabolism in opioid addicts: implications for clinical treatment. J Psychoactive Drugs 1991; 23: 135-49.

  36. Ragni G, De Laurentis L, Gambaro V, Di Pietro R, Bestetti O, Recalcati F, Papetti C. Semen evaluation in heroin and methadone addicts. Acta Eur Fertil 1985; 16: 245-9.

  37. Green M, Zelson C, Behrendt H. Sweating function in the heroin withdrawal syndrome of neonates. Int J Addict 1974; 9: 495-502.

  38. Gorsky M, Buchner A, Fundoianu-Dayan D, Cohen C. Fordyce’s granules in the oral mucosa of adult Israeli Jews. Community Dent Oral Epidemiol 1986; 14: 231-2.




2020     |     www.medigraphic.com